CYP27A1
CYP27A1 (sterol 26-hydroxylase, also known as CTX, CP27 and CYP27) is a mitochondrial cytochrome P450 monooxygenase that hydroxylates cholesterol and its derivatives. It converts excess cholesterol towards bile acids and is central to cholesterol homeostasis. Browse Assay Genie's current range of CYP27A1 research reagents below, or read on for the biology behind the target.
CYP27A1 is a cytochrome P450 monooxygenase that catalyses regio- and stereospecific hydroxylation of cholesterol and its derivatives. It hydroxylates the terminal methyl group of the cholesterol side-chain with R stereochemistry in a three-step reaction, giving first a C26 alcohol, then a C26 aldehyde and finally a C26 acid. By converting excess cholesterol to bile acids through both the neutral (classic) and acid (alternative) pathways, the enzyme regulates cholesterol homeostasis. Because this conversion is the major route for removing cholesterol from the body, CYP27A1 is important for overall cholesterol balance.
The enzyme may also act through oxysterols. These can serve as ligands for the nuclear receptors NR1H2 and NR1H3, modulating transcription of genes involved in lipid metabolism. CYP27A1 converts 7-ketocholesterol into 7-keto,27-hydroxycholesterol, an oxysterol that activates smoothened (SMO) and the smoothened signalling pathway. It also hydroxylates cholestanol, plays a role in cholestanol metabolism in the cerebellum, and may facilitate sterol diffusion across the blood-brain barrier. It acts on retinal 7-ketocholesterol, a pro-inflammatory and pro-apoptotic oxysterol, and may contribute to its elimination from the retinal pigment epithelium. In addition, it may play a redundant role in vitamin D biosynthesis, catalysing 25-hydroxylation of vitamin D3.
The CYP27A1 gene encodes a member of the cytochrome P450 superfamily, whose monooxygenases act in drug metabolism and in the synthesis of cholesterol, steroids and other lipids. The protein sits in the inner mitochondrial membrane and is classed in the cytochrome P450 family 27 gene group. Its alias CTX reflects the disease it causes: mutations in the gene cause cerebrotendinous xanthomatosis, a rare autosomal recessive lipid storage disease. Mouse and rat orthologs are both named Cyp27a1, which supports work in rodent models of sterol metabolism.
CYP27A1 oxidises cholesterol intermediates in the bile synthesis pathway, acting in both the neutral and acid routes of cholesterol conversion.
Converting excess cholesterol to bile acids is the major route of cholesterol removal, making CYP27A1 a focus for lipid metabolism studies.
Mutations in CYP27A1 cause cerebrotendinous xanthomatosis, a rare autosomal recessive lipid storage disease, so the enzyme is key to studying this disorder.
CYP27A1 generates oxysterols that act on NR1H2, NR1H3 and smoothened, linking sterol metabolism to nuclear receptor and SMO signalling.
CYP27A1 is a mitochondrial cytochrome P450 monooxygenase that hydroxylates the cholesterol side-chain in three steps, giving a C26 alcohol, aldehyde and then acid. This drives conversion of cholesterol to bile acids and supports cholesterol homeostasis. It also hydroxylates other sterols and vitamin D3.
The HGNC name is cytochrome P450 family 27 subfamily A member 1, and the UniProt name is sterol 26-hydroxylase, mitochondrial. Aliases include CTX, CP27 and CYP27. Earlier names refer to steroid 27-hydroxylase and cerebrotendinous xanthomatosis, polypeptide 1.
Mutations in the CYP27A1 gene cause cerebrotendinous xanthomatosis, a rare autosomal recessive lipid storage disease. Mouse and rat each have an ortholog named Cyp27a1. Check the datasheet of any product for its validated reactivity.
Other cytochrome P450 enzymes involved in sterol, steroid and vitamin D metabolism with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q02318; product specifications from Assay Genie datasheets.